Company / Capital Expenditures
McKesson Corporation Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$436.0M
FY2025
5-year range
$362.0M / $537.0M
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#27 of 150
Health Care
What the data says
McKesson Corporation's capital expenditures of $436M is higher than 82% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 9 years, ranging from $362M in FY2022 to $537M in FY2024.
Based on SEC 10-K filings.
$436M in FY2025 with a 5-year CAGR of +1.5%. Top quartile in the Health Care sector.
Declined from $451M to $436M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
+60.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.5%, indicating consistent growth.
- In FY2025, capital expenditures decreased 18.8% year-over-year.
- Ranks #27 out of 150 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $436.0M | -18.8% |
| FY2024 | $537.0M | +19.1% |
| FY2023 | $451.0M | +24.6% |
| FY2022 | $362.0M | -15.0% |
| FY2021 | $426.0M | +5.2% |
| FY2020 | $405.0M | +0.2% |
| FY2019 | $404.0M | -17.2% |
| FY2018 | $488.0M | +29.8% |
| FY2017 | $376.0M | -6.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026